Published January 23, 2026
| Version v1
Dataset
Open
ZAMONAVIY FARMAKOTERAPIYA BILAN ALLERGIK RINITNI DAVOLASH: QIYOSIY KO'RIB CHIQISH
Authors/Creators
- 1. Toshkent Davlat Tibbiyot Universiteti
- 2. Worldly Knowledge Publishing Centre
Description
Ushbu sharh maqola allergik rinit (AR) ni zamonaviy farmakoterapiya usullari bilan davolashning qiyosiy tahlilini taqdim etadi. 2020–2025 yillardagi sistematik sharhlar va meta-analizlarga asoslanib, intranazal kortikosteroidlar (INCS) va ularning intranazal antigistaminlar bilan kombinatsiyalari alomatlarni (ayniqsa burun bitishi) nazorat qilish va hayot sifatini yaxshilashda eng yuqori samaradorlikni ko‘rsatdi. Oral antigistaminlar yengil holatlarda mos keladi, leykotrien antagonistlari va biologik preparatlar esa astma bilan birgalikda va refrakter shakllarda qo‘llaniladi. Natijalar ARIA 2023–2025 yo‘riqnomalariga mos kelib, INCS dan boshlab bosqichma-bosqich terapiyani tavsiya qiladi.
Files
1877-1888.pdf
Files
(279.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:1f96e13d28a595578ca9163be0dadac8
|
279.9 kB | Preview Download |
Additional details
References
- Bousquet J, et al. (2025). Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines: Intranasal Treatments. Allergy, 81(12), 1567-1598.
- Brożek JL, et al. (2020). Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2019 revision. Journal of Allergy and Clinical Immunology, 145(1), 1-12.
- Dykewicz MS, et al. (2020). Rhinitis 2020: A practice parameter update. Journal of Allergy and Clinical Immunology, 146(4), 721-767.
- Feng Y, et al. (2024). Efficacy and safety of intranasal medications for allergic rhinitis: A systematic review and meta-analysis. Allergy, 79(11), 2890-2905.
- Greiner AN, et al. (2023). Comparative efficacy of intranasal corticosteroids for allergic rhinitis. Frontiers in Pharmacology, 14, 1184552.